11-dehydro-txb2

Introduction

To understand associated biological information of 11-dehydro-txb2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 11-dehydro-txb2?

11-dehydro-txb2 is suspected in Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis, Chronic ischemic heart disease NOS, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 11-dehydro-txb2

MeSH term MeSH ID Detail
Cerebrovascular Disorders D002561 25 associated lipids
Polycythemia Vera D011087 13 associated lipids
Hyperlipidemias D006949 73 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Albuminuria D000419 18 associated lipids
Renal Artery Obstruction D012078 8 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Atherosclerosis D050197 85 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Per page 10 20 | Total 20

PubChem Associated disorders and diseases

What pathways are associated with 11-dehydro-txb2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 11-dehydro-txb2?

There are no associated biomedical information in the current reference collection.

What functions are associated with 11-dehydro-txb2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 11-dehydro-txb2?

There are no associated biomedical information in the current reference collection.

What genes are associated with 11-dehydro-txb2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 11-dehydro-txb2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 11-dehydro-txb2

Download all related citations
Per page 10 20 50 100 | Total 283
Authors Title Published Journal PubMed Link
Kawamura M et al. Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. 1995 Thromb. Res. pmid:7778061
Chiabrando C et al. Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat. 1994 Prostaglandins pmid:7938613
Wallén NH et al. Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. 1994 Br J Clin Pharmacol pmid:7946939
Pape HC et al. Does the reamer type influence the degree of lung dysfunction after femoral nailing following severe trauma? An animal study. 1994 J Orthop Trauma pmid:7965291
Kitano A et al. Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. 1994 Headache pmid:8002323
Larsson PT et al. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. 1994 Circulation pmid:8181117
Djurup R et al. Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. 1993 Clin. Chem. pmid:8252718
Smith SR et al. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. 1993 Transplantation pmid:8279014
van Kooten F et al. Evidence for episodic platelet activation in acute ischemic stroke. 1994 Stroke pmid:8303731
Foegh ML et al. Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. 1994 J. Intern. Med. pmid:8308478
Chiabrando C et al. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. 1993 Prostaglandins pmid:8321910
Takasaki W et al. Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. 1993 Thromb. Res. pmid:8367836
Schiff E et al. Reduction of thromboxane A2 synthesis in pregnancy by polyunsaturated fatty acid supplements. 1993 Am. J. Obstet. Gynecol. pmid:8420313
Van Assche FA et al. Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia. 1993 Am. J. Obstet. Gynecol. pmid:8420355
Koudstaal PJ et al. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. 1993 Stroke pmid:8421822
Foulon I et al. Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. 1993 Arterioscler. Thromb. pmid:8443146
Chen HI et al. Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats. 1993 Acta Physiol. Scand. pmid:8452036
Ciabattoni G et al. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. 1993 J. Am. Coll. Cardiol. pmid:8473644
Yasu T et al. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. 1993 Am. J. Cardiol. pmid:8480641
Yamanaka S et al. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. 1993 Prostaglandins pmid:8484010